www.fdanews.com/articles/133902-rosetta-launches-collaborations-to-advance-fluids-based-diagnostic-tests

Rosetta Launches Collaborations to Advance Fluids-Based Diagnostic Tests

February 1, 2011

Rosetta Genomics, Ltd. announced that it has signed two new agreements for the development and validation of microRNA-based diagnostics for various indications related to its Gen 3 products.
iStockAnalyst